406 related articles for article (PubMed ID: 15677848)
1. Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthrax.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E3-4. PubMed ID: 15677848
[TBL] [Abstract][Full Text] [Related]
2. Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemia.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E9-10. PubMed ID: 15677845
[TBL] [Abstract][Full Text] [Related]
3. Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthrax.
Bossi P; Tegnell A; Baka A; van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G
Euro Surveill; 2004 Dec; 9(12):21-22. PubMed ID: 29183499
[TBL] [Abstract][Full Text] [Related]
4. Bichat guidelines for the clinical management of smallpox and bioterrorism-related smallpox.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E7-8. PubMed ID: 15677846
[TBL] [Abstract][Full Text] [Related]
5. Bichat clinical guidelines for bioterrorist agents.
Bossi P; Van Loock F; Tegnell A; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E1-2. PubMed ID: 15677849
[No Abstract] [Full Text] [Related]
6. Bichat guidelines for the clinical management of Q fever and bioterrorism-related Q fever.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E19-20. PubMed ID: 15677840
[TBL] [Abstract][Full Text] [Related]
7. Bichat guidelines for the clinical management of botulism and bioterrorism-related botulism.
Bossi P; Tegnell A; Baka A; van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E13-4. PubMed ID: 15677843
[TBL] [Abstract][Full Text] [Related]
8. Bichat guidelines for the clinical management of plague and bioterrorism-related plague.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E5-6. PubMed ID: 15677847
[TBL] [Abstract][Full Text] [Related]
9. Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E15-6. PubMed ID: 15677842
[TBL] [Abstract][Full Text] [Related]
10. Bichat guidelines for the clinical management of viral encephalitis and bioterrorism-related viral encephalitis.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E21-2. PubMed ID: 15677839
[TBL] [Abstract][Full Text] [Related]
11. Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosis.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E17-8. PubMed ID: 15677841
[TBL] [Abstract][Full Text] [Related]
12. Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E11-2. PubMed ID: 15677844
[TBL] [Abstract][Full Text] [Related]
13. Bioterrorism, Glanders and melioidosis.
Cheng AC; Dance DA; Currie BJ
Euro Surveill; 2005 Mar; 10(3):E1-2; author reply E1-2. PubMed ID: 15827368
[No Abstract] [Full Text] [Related]
14. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
[TBL] [Abstract][Full Text] [Related]
15. [Update on biological weapons and bioterrorism. Important that health services pay attention to unusual events].
Roffey R; Lantorp K; Tegnell A; Elgh F
Lakartidningen; 2001 Dec; 98(50):5746-8, 5751-2. PubMed ID: 11789096
[TBL] [Abstract][Full Text] [Related]
16. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?
Mayer TA; Morrison A; Bersoff-Matcha S; Druckenbrod G; Murphy C; Howell J; Hanfling D; Cates R; Pauze D; Earls J
Clin Infect Dis; 2003 May; 36(10):1275-83. PubMed ID: 12746773
[TBL] [Abstract][Full Text] [Related]
17. [Anthrax--an overview at 2002].
Mozes YN; Winder A; Tadmor B; Rotman E; Sagi R; Hourvitz A
Harefuah; 2002 May; 141 Spec No():63-72, 121, 120. PubMed ID: 12170557
[TBL] [Abstract][Full Text] [Related]
18. Our first line of defense against bioterrorism part 2.
Simpson RL
Nurs Manage; 2002 May; 33(5):10, 11. PubMed ID: 12006878
[TBL] [Abstract][Full Text] [Related]
19. Preparedness for an anthrax attack.
Franz DR
Mol Aspects Med; 2009 Dec; 30(6):503-10. PubMed ID: 19619577
[TBL] [Abstract][Full Text] [Related]
20. Anthrax: new threat from an ancient microbe.
Woods A
Nursing; 2002 Jan; 32(1):44-5. PubMed ID: 12352747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
